Our observations are in line with previous reports indicating that the loss of E-cadherin expression is associated with a poor prognosis in gradeIII of colorectal cancer (24), and the overexpression of N-cadherin can provide a clinical prognostic predictor in patients with CRC (25). The gene discussed is CDH2; the disease is colorectal carcinoma.